ProMore Pharma's IPO

ProMore Pharma raised a round of funding on July 06, 2017. Investors include Public.

Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides for the bioactive wound care market. The company has two therapeutic peptides, PXL01 and LL-37, in …

Articles about ProMore Pharma's IPO: